Grant-Specific Novel Coronavirus (COVID-19) Links

April 3, 2020 at 08:17:35 ET
Image Image

The following provides a list of links to memoranda and guidance issued by federal agencies specifically relevant to grant applicants and recipients that detail how impacts created by the Novel Coronavirus (COVID-19) will affect their programs. This list will be continuously updated as agencies provide more information to the grants community as to how to proceed with applying for and managing their awards under their programs.

Congress

Coronavirus Aid, Relief, and Economic Security Act (CARES Act) (Pub. L. 116-136)

Families First Coronavirus Response Act (Pub. L. 116-127)

Office of Management and Budget

M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations

M-20-11: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) Department of Agriculture

Department of Agriculture

National Institute of Food and Agriculture

NIFA-20-005 NIFA Coronavirus FAQs

NIFA Deadline Extensions Due to COVID-19

Rural Development

USDA Implements Immediate Measures to Help Rural Residents, Businesses and Communities Affected by COVID-19

Department of Defense

Army Research Office

Coronavirus Disease 2019 (COVID-19) Latest Information and Guidance

Office of Naval Research

Coronavirus Assistance and Acquisition-Related Information and Resources

U.S. Army Medical Research Acquisition Activity

USAMRAA’s COVID-19 FAQs

Department of Education

Key Policy Letters Signed by the Education Secretary or Deputy Secretary

Office of Civil Rights

Fact Sheet: Addressing the Risk of COVID-19 in Schools While Protecting the Civil Rights of Students

Office of Postsecondary Education

Guidance for Interruptions of Study Related to Coronavirus (COVID-19)

Office of Federal Student Aid

Coronavirus Information for Students, Borrowers, and Parents

Department of Energy

Accommodating Interruptions from Coronavirus Disease 2019

Department of Health and Human Services

ORI Guidance to Institutions Concerning Sequestration during Closure of Institutions Due to COVID-19

ORI Operations Status during Public Health Emergency (COVID-19)

Food and Drug Administration

FDA – Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

National Institutes of Health

New OLAW COVID-19 Pandemic Contingency Planning Webpage

UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients

OLAW Guidance in Preparing for the Coronavirus Disease 2019 (COVID-19) Outbreak

Special OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care

Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19

Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19

General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19

NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19

FAQs on COVID-19 Flexibilities for Applicants and Recipients

Department of Homeland Security

Federal Emergency Management Agency

Coronavirus (COVID-19) Pandemic: Public Assistance Simplified Application

Coronavirus (COVID-19) Response: Tribal Recipients

Procurement Under Grants: Under Exigent or Emergency Circumstances

Coronavirus (COVID-19) Pandemic: Eligible Emergency Protective Measures

Public Assistance: Non-Congregate Sheltering Delegation of Authority

COVID-19 Emergency Declaration

Department of Housing and Urban Development

Frequently Asked Questions (FAQ) About the Coronavirus Disease (COVID-19) for Fair Housing Initiatives Program (FHIP) Grantees and Applicants

Quick Guide to CDBG Eligible Activities to Support Infectious Disease Response

Using Continuum of Care Program Funds for Infectious Disease Preparedness and Response

Eligible ESG Program Costs for Infectious Disease Preparedness

COVID-19 FAQs for the Public Housing, Housing Choice Voucher (HCV) (including the Project-based Voucher Program (PBV)) and Native American Programs

Quick Guide to CDBG Eligible Activities to Support Infectious Disease Response

Department of Transportation

Federal Transit Administration

Emergency Relief Docket

Frequently Asked Questions from FTA Grantees Regarding Coronavirus Disease 2019 (COVID-19)

Environmental Protection Agency

EPA Frequent Questions on Grant Issues in Response to the Novel Coronavirus (COVID-19) Public Health Emergency

National Aeronautics and Space Administration

Assistant Administrator for Procurement Message on Coronavirus

National Science Foundation

NSF Implementation of OMB Memorandum M-20-17

Important Notice No. 146: NSF Letter to Community Regarding COVID-19

Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees

Impact on Existing Deadline Dates

NSF Guidance for Major Facilities and Contracts Regarding COVID-19

 

My Research Folders

You are not Logged in yet, Please login to see Your research folders.